Translational Science

Never before has the industry moved so rapidly to find new treatments and vaccines – but safety and efficacy must remain top priorities.

What lies beyond COVID-19? There are many diseases that could benefit from all the collaborative effort and funding being poured into COVID-19.

NASA ultimately wants to send humans to Mars – and those humans will need medicines.

Drug development needs to move more rapidly, but not at the expense of safety.

Your roundup of the key scientific studies and industry announcements emerging from the pandemic.

A clinical trial tracker aims to encourage international collaboration on COVID-19 drug development.

The development of a CMV vaccine has been 50 years in the making.

Why are compounds still failing at the final hurdle?

John Rossi, Director of Translational Sciences at Kite Pharma, talks about bright future of CAR T cell therapy.

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."